If the generic doesn't get out there then the pharmaceutical company (with the patent) obviously benefits. |
Merck is not dumb. They're not in the business of losing money. |
The more the two companies discussed co-heads, the more difficult it became. |
These are the two biggest companies in the cholesterol segment, companies with combined annual revenues of $12 billion, and (the guidelines) could add a couple of billion to each company over five years. |